BIOF · Insider Trading
BLUE BIOFUELS INC
Every open-market purchase and sale reported by BIOF officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2014-10-21 | Third Point LLC | Director | X | +14,580,072 | +$72.90M |
| 2014-08-07 | Scott H Pearce | President & CEO | Sell | −43,515 | −$416.68K |
| 2014-07-11 | Scott H Pearce | President & CEO | MIXED | — | — |
| 2012-08-31 | THIRD POINT PARTNERS LP | 10%+ Owner | J | +208,146 | — |
| 2012-08-31 | Scott H Pearce | President and CEO | J | −16,922 | — |
| 2012-08-29 | GREENLIGHT CAPITAL QUALIFIED, L.P. | 10%+ Owner | J | +693,820 | — |
| 2012-06-13 | Scott H Pearce | President & CEO | MIXED | — | — |
| 2012-03-22 | John D. March | Director | A | +15,000 | — |
| 2012-03-22 | Mark L. Zoeller | V.P., General Counsel | A | +162,000 | — |
| 2012-03-22 | Ernest J Sampias | Director | A | +15,000 | — |
| 2012-03-22 | Richard I Jaffee | Director | A | +15,000 | — |
| 2012-03-22 | Elizabeth Blake | Director | A | +15,000 | — |
| 2012-03-22 | Mark Wong | Director | A | +177,000 | — |
| 2012-03-22 | Scott H Pearce | President and CEO | A | +477,000 | — |
| 2012-03-22 | Kelly G. Maguire | Exec. VP and CFO | A | +270,000 | — |
| 2012-03-19 | GREENLIGHT CAPITAL INC | 10%+ Owner | A | +150,000 | — |
| 2012-01-17 | DME Advisors GP, L.L.C. | 10%+ Owner | J | — | — |
| 2011-11-28 | Thomas J Edelman | 10%+ Owner | Sell | −1,283,077 | −$746.62K |
| 2011-11-15 | Cargill Biofuels Investments, LLC | — | Sell | −1,235,570 | −$757.60K |
| 2011-11-10 | Cargill Biofuels Investments, LLC | 10%+ Owner | Sell | −256,830 | −$151.82K |
| 2011-11-08 | Cargill Biofuels Investments, LLC | 10%+ Owner | Sell | −854,700 | −$515.09K |
| 2011-06-14 | Scott H Pearce | President and CEO | MIXED | — | — |
| 2011-06-13 | Cargill Biofuels Investments, LLC | 10%+ Owner | Sell | −5,121 | −$2.94K |
| 2011-03-23 | Thomas J Edelman | 10%+ Owner | Sell | −274,845 | −$381.78K |
| 2011-03-23 | Thomas J Edelman | 10%+ Owner | MIXED | −3,487,890 | −$3.67M |
| 2011-03-17 | Richard I Jaffee | Director | A | +25,000 | — |
| 2011-03-17 | John D. March | Director | A | +25,000 | — |
| 2011-03-17 | Scott H Pearce | President and CEO | A | +350,000 | — |
| 2011-03-17 | Elizabeth Blake | Director | A | +25,000 | — |
| 2011-03-17 | Ernest J Sampias | Director | A | +25,000 | — |
| 2011-03-17 | Kelly G. Maguire | Executive VP and CFO | A | +285,000 | — |
| 2011-03-17 | Mark Wong | Director | A | +500,000 | — |
| 2011-03-17 | Mark L. Zoeller | V. P., General Counsel | A | +120,000 | — |
| 2011-03-17 | GREENLIGHT CAPITAL LLC | 10%+ Owner | A | +250,000 | — |
| 2011-02-09 | Mark Wong | Director | A | +25,216 | +$14.12K |
| 2011-02-09 | John D. March | Director | A | +12,608 | +$7.06K |
| 2011-02-09 | Elizabeth Blake | Director | A | +25,216 | +$14.12K |
| 2011-02-09 | Ernest J Sampias | Director | A | +6,304 | +$3.53K |
| 2011-02-09 | Kelly G. Maguire | Exec. Vice President and CFO | A | +211,798 | +$118.61K |
| 2011-02-09 | Elizabeth Blake | Director | A | +25,216 | +$14.12K |
| 2011-02-09 | Scott H Pearce | President and CEO | A | +1,015,196 | +$568.51K |
| 2011-02-08 | Greenlight Capital (Gold), LP | Director | A | +309,345,040 | +$173.23M |
| 2010-12-20 | Scott H Pearce | President and CEO | Sell | −23,588 | −$41.34K |
| 2010-12-16 | Scott H Pearce | President and CEO | Sell | −85,102 | −$148.93K |
| 2010-12-10 | Scott H Pearce | President and CEO | Sell | −10,100 | −$17.68K |
| 2010-12-07 | Scott H Pearce | President and CEO | Sell | −109,610 | −$178.42K |
| 2010-12-03 | Scott H Pearce | President and CEO | Sell | −151,600 | −$231.39K |
| 2010-12-02 | Scott H Pearce | President and CEO | D | −20,000 | −$33.56K |
| 2010-09-24 | David Einhorn | Director | J | — | −$0 |
| 2010-05-28 | David Einhorn | Director | A | +5,000 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BIOF quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.